ANIMAL TRANSGENESIS IN BIOMEDICAL APPLICATION- A REVIEW

ABSTRACT

Transgenesis is radically a new technology for altering the characteristics of animals by directly changing the genetic material. There has been rapid development in the use of genetically engineered animals as investigators have found an increasing number of applications for the technology. Transgenic technology holds great potential in agriculture, medicine and industry. This article lays emphasis on the Bio-medical applications of transgenesis.

KEYWORDS

REFERENCES

Adel M., Aboul-Naga and Ahmed R. Elbeltagy (2007). Animal Biotechnology: Applications and Implications in the Near East & North Africa (NENA) Countries. Animal Biotechnology: Potential Applications. 9 : 86:93..
Auchincloss H, Jr.,Sach. D. H,(1998). Xenogenic transplantation .Annu Rev Immunol 16: 433-470.
Cavazzana-Calvo M, Fischer A. (2007). “Gene therapy for severe combined immunodeficiency: are we there yet?”. J. Clin. Invest. 117 (6): 1456–65.
Diamond, L E.,Quinn C.M., Martin, M. J., Lawson J, Platt, J. L., Logan, J.S. (2001). Ahuman CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 71:132-142. Ebert, K. M. , Selgrath, J .P. , DiTullio P, Denman J, Smith, T. E., Memon, M.A.(1991). Transgenic production of a variant of human tissue – type plasminogen activator In goat milk : generation of transgenic goats and analysis of expression. Biotechnology(NY) 9:835-838.
Elder, G. A., Gama Sosa, M. A. and De Gasperi, R. (2010), Transgenic Mouse Models of Alzheimer’s Disease. Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 77: 69–81.
FELASA (Federation of European Laboratory Animal Science Associations) September 1982, revised February 1995. Transgenic Animals — Derivation, Welfare, Use and Protection.
Fodor,W.L,,Williams, B.L., Matis, L.A,,Madri J.A,,Rollins S.A,,Knight ,J.W. et al .(1998). inhibitor in a transgenic pig as a model for the prevention of xenogenic hyper acute organ rejection. Proc Natl Acad Sci USA 91:11153- 11157.
Foster K, Foster H, Dickson JG .(2006). “Gene therapy progress and prospects: Duchenne muscular dystrophy”. Gene Ther. 13 (24): 1677–85.
Frank Gwazdauskas, (1992) “Transgenic Animals in the Production of Therapeutic Proteins.” Biotechnology International. Century Press, p. 317.
Gordon, J.W., G.A. Scangos, D.J. Plotkin, A. Barbosa and F.H. Ruddle. (1980). “Genetic transformation of mouse embryos by microinjection.” Proceedings of Nat. Acad. Sci. USA 77: 7380-7384.
Hammer, R.E., V.G. Pursel, C.E. Rexroad, R.J. Wall, D.J. Bolt, K.M. Ebert,R.D Palmiter and R.L. Brinster. (1985). “Production of transgenic rabbits,sheep, and pigs by microinjection.” Nature 315: 680-683.
Hoagland, T.A., M. Julian, J.W., Riesen, D. Schrieber and W.L. Fodor. (1997). “Transgenic pigs as animal model for xenogenic transplantation.” Theriogenology 47: 224.
Jixiang Xia, Angela Martinez, Henry Daniell and Steven N Ebert (2011) Evaluation of biolistic gene transfer methods in vivo using non-invasive bioluminescent imaging techniques.BMC Biotechnol. 11: 62.
Kues, W.A ., Niemann H. .(2011). Advances in farm animal transgenesis. Prev Vet Med. 102 (2): 146-56
Kuroiwa Y, Kaisenathan P, Matsushita H, Sathiaselan J, Sullivan E. J, Kakitani M, (2004). Sequential targeting of gene encoding immunoglobim-mu and prion protein in cattle. Nat Genet 36:775-780.
Lewitt, P. A.; Rezai, A. R.; Leehey, M. A.; Ojemann, S. G.; Flaherty, A. W.; Eskandar, E. N.; Kostyk, S. K.; Thomas, K. (2011). “AAV2-GAD gene therapy for advanced Parkinson’s disease: A double-blind, sham-surgery controlled, randomised trial”. The Lancet Neurology 10 (4): 309–319
Gallaher, et al (2011). Gene therapy ‘treats’ Parkinson’s disease BBC News Health, 17 March 2011, Retrieved 24 April 2011
McKee C, Gibson A, Dalrymple M, Emslie L, Garner I, Cottingham I. (1998). Production of biologically active salmon calcitotin in the milk of transgenic rabbits. Natt Bitechnol 16:647-651.
Niemann H, Halter R, Carnwath, J .W., Hermann D, Lemme E, Paul D.(1999). Expession of human blood clotting factor VIII in the mammary gland of transgenic sheep. Transgenic Res 8:237-247.
Niemann, H., Kues, W.A. Petersen, B. Carnwath J.W. (2011). Transgenesis. Comprehensive Biotechnology (Second Edition) 4 : 457-467
Phelps C.J., Koike C., Vaught T.D., Boone J., Wells K.D., Chen S.H., Ball S., Specht S.M., Polejaeva I.A., Monahan J.A., Jobst P.M., Sharma S.B., Lamborn A.E., Garst A.S., Moore M., Demetris A.J., Rudert W.A., Bottino R., Bertera S., Trucco M., Starzl T.E., Dai Y. & Ayares D.L. (2003). Production of alpha 1,3-galactosyltransferase- deficient pigs. Science. 299: 411-414
Persons DA, Nienhuis AW (2003).”Gene therapy for the hemoglobin disorders”. Curr. Hematol. Rep. 2 (4): 348–55.
Roschlau, K., P. Rommel, L. Andreewa, M. Zackel, D. Roschlau, B. Zackel, M. Schwerin, M. Huhn and K.G. Gazarjan. (1989). “Gene transfer experiments in cattle.” J. Repro. Fertility (Suppl.) 38: 153-160.
Rosenecker J, Huth S, Rudolph C. (2006). “Gene therapy for cystic fibrosis lung disease: current status and future perspectives”. Curr. Opin. Mol. Ther. 8 (5): 439–45.
Schnieke,A .E., Kind, A. J., Ritchie, W. A., Mycock ,K., Scott ,A. R., Ritchie M, Wilmut I,et al. (1997). Human factor IX transgenic sheep produced by transfer of nuclei transfected foetal fibroblasts. Science 278:2130-2133.
Selkirk SM. (2004). “Gene therapy in clinical medicine”. Postgrad Med J 80 (948): 560–70.
Tai H.C., Ezzelarab M., Hara H., Ayares D. & Cooper D.K. (2007). Progress in xenotransplantation following the introduction of gene knockout technology. Transplant International. 20: 107-117.
Wright G,Carver A, Cottom D, Reeves D, Scot A, Simsons P, et al.(1991). High level expression of active human alpha -1-antitrypsin in the milk of transgenic sheep. Biotechnology (NY) 9:830-834.
Zaidi A, Schmoeckel M, Bhatti F, Waterworth P,Tolan M, Cozzi E, et al.(1998). Life supporting pig to primate renal xenotransplantation using genetically modified donors. Transplantation 65:1584-1590.
Zabetian, M., Tahmoorespur M and Hosseinie, KH. The Applications of Transgenic Rabbits in Agriculture and Biomedicine (2011) .J. Ani. Vety. Adv., 10: 780-790.

Disclaimer :

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Copyright :

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

ANIMAL TRANSGENESIS IN BIOMEDICAL APPLICATION- A REVIEW

ABSTRACT

KEYWORDS

REFERENCES

Reviewed By

In this Article

APC

Publish With US

Become a Reviewer/Member

Open Access

Products and Services

Support and Policies

Editorial Board